During the recent STAT @ ASH event in San Diego, panelists explored the role of community oncology in advancing precision medicine for cancer care.
Oncology &
Specialty
Solutions
Meet McKesson at ASCO 2025
As a leader in healthcare, we’re always advancing cancer research and care through our expertise in precision medicine, clinical trials, insights and advanced technology to support patient outcomes. Join our experts at ASCO for five days of sessions, networking opportunities and more.
Don’t miss the Endpoints at ASCO virtual panel sponsored by McKesson at 12:10 p.m. ET on June 4, where we will discuss insights and innovative solutions shaping the future of oncology.
Accelerating Cancer Research and Care
We support cancer research and care by enabling deep collaboration between biopharma companies and oncology providers.
Our portfolio of oncology solutions aims to address hurdles at every stage of the clinical process and improve outcomes by accelerating drug development and clinical trial activation, expanding access to cancer care closer to home and delivering real-world data and evidence to advance care.
We accelerate oncology innovation to help providers, biopharma companies and payers strengthen their businesses and deepen patient connections.
We work with biopharma companies, care providers, pharmacies and others to make cancer care more accessible and affordable.
Through our legacy expertise in supply chain solutions and our patient-first approach, we help ensure therapies are available, accessible and affordable.
Learn about McKesson’s new Cell and Gene Therapy (CGT) brand, InspiroGene, and the launch of a first-of-its-kind report about the CGT landscape and its future trajectory.
Leading experts from an Endpoints News panel share actions that can be taken to foster equitable access and improve outcomes for cancer patients.
top